Skip to content

The Emerging Role of Dapagliflozin in Right Ventricular Dysfunction and Pulmonary Hypertension in Patients with Heart Failure with Reduced and Mildly Reduced Ejection Fraction

Aug 2026 · Journal of Pharmaceutical Innovation · Vol 22 · 0 citations · 40 references
View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.